Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-16828-x.pdf
Reference23 articles.
1. Creeke, P. I. & Farrell, R. A. Clinical testing for neutralizing antibodies to interferon-β in multiple sclerosis. Ther. Adv. Neurol. Disord. 6, 3–17 (2013).
2. Polman, C. H. et al. Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis. Lancet Neurol. https://doi.org/10.1016/S1474-4422(10)70103-4 (2010).
3. Deisenhammer, F. Neutralizing antibodies to interferon-beta and other immunological treatments for multiple sclerosis: prevalence and impact on outcomes. CNS Drugs 23, 379–96 (2009).
4. Basser, R. The impact of thrombopoietin on clinical practice. Curr Pharm Des 8, 369–377 (2002).
5. Sominanda, A. et al. Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta. Arch. Neurol. 67, 1095–101 (2010).
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids;Phytomedicine;2023-04
2. MicroRNAs as a possible biomarker in the treatment of multiple sclerosis;IBRO Neuroscience Reports;2022-12
3. Multiple Sclerosis is a Risk Factor for Hyperthyroidism and Interferon Beta Action on Thyroid Hormones via Novel Immuno-neuro-enzymological Mechanisms;Al Mustansiriyah Journal of Pharmaceutical Sciences;2022-04-18
4. Influenza A pathway analysis of highly pathogenic avian influenza virus (H5N1) infection in genetically disparate Ri chicken lines;Veterinary Immunology and Immunopathology;2022-04
5. Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies;RSC Chemical Biology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3